Marcus Research Laboratory
United States Updated 9 July 2026
Marcus Research Laboratory is an API manufacturer based in United States. It holds one active US drug master file. Its GMP standing is certified by US FDA. Its most recent recorded inspection, by US FDA, closed on 12 July 2024 as VAI.
1
registered plants
1 with an FDA FEI number
0
filings
across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Inspections
8 of 8 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.
Inspection history
- 12 July 2024 VAI US FDA
- 2 September 2022 OAI US FDA
- 14 May 2021 OAI US FDA
- 6 December 2019 OAI US FDA
- 6 April 2017 VAI US FDA
- 20 June 2014 VAI US FDA
- 6 July 2012 VAI US FDA
- 14 March 2011 OAI US FDA
NAI means no action indicated, VAI means voluntary action indicated, and OAI means
official action indicated.
Registered plants
| Site | FDA FEI |
| Saint Louis, United States | 1950348 |
What they file, and where
Also appears on these molecule pages
Filings and GMP by regulator
| Regulator | Filings | GMP certificates |
| US FDA | None | 1 |
Comparing suppliers?
Choose your molecules and target markets. Marcus Research Laboratory comes back tiered against every other
supplier able to file there.
Start for free No sales call.
Open risk flags
- The most recent inspection outcome was VAI, on 12 July 2024.
Sources on this page
- FDA
- Drug master files, establishment registration, inspection classifications
- EDQM
- Certificates of suitability
- EudraGMDP and national regulators
- GMP certificates